Evidence map›Paper›PMID 32714144›Full record

ArticleFrontiers in molecular neuroscience2020

P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases.

Abraham J Cisneros-Mejorado, Alberto Pérez-Samartín, María Domercq, Rogelio O Arellano, Miroslav Gottlieb, Friedrich Koch-Nolte, Carlos Matute

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Abraham J Cisneros-MejoradoInstituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Alberto Pérez-SamartínAchucarro Basque Center for Neuroscience, Departamento de Neurociencias, Universidad del País Vasco, CIBERNED, Leioa, Spain.
María DomercqAchucarro Basque Center for Neuroscience, Departamento de Neurociencias, Universidad del País Vasco, CIBERNED, Leioa, Spain.
Rogelio O ArellanoInstituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Miroslav GottliebInstitute of Neurobiology, Slovak Academy of Sciences, Kosice, Slovakia.
Friedrich Koch-NolteDepartment of Immunology, University Hospital, Hamburg, Germany.
Carlos MatuteAchucarro Basque Center for Neuroscience, Departamento de Neurociencias, Universidad del País Vasco, CIBERNED, Leioa, Spain.
Universidad Nacional Autónoma de México · MXUniversity of the Basque Country · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESSlovak Academy of Sciences · SKUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shortage of oxygen and nutrients in the brain induces the release of glutamate and ATP that can cause excitotoxicity and contribute to neuronal and glial damage. Our understanding of the mechanisms of ATP release and toxicity in cerebrovascular diseases is incomplete. This review aims at summarizing current knowledge about the participation of key elements in the ATP-mediated deleterious effects in these pathologies. This includes pannexin-1 hemichannels, calcium homeostasis modulator-1 (CALHM1), purinergic P2X7 receptors, and other intermediaries of CNS injury downstream of ATP release. Available data together with recent pharmacological developments in purinergic signaling may constitute a new opportunity to translate preclinical findings into more effective therapies in cerebrovascular diseases.

Indexed as

ATPischemianeuronoligodendrocytepannexin-1

Identifiers

PMID32714144
PMCPMC7340211
OpenAlexW3036671933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.